NEOGENOMICS INC (NEO)
US64049M2098 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -84.23M | -87.97M | -144.25M | -8.35M | 4.17M | |||
| Depreciation Amortization | 73.02M | 72.58M | 69.43M | 53.35M | 35.72M | |||
| Change In Working Capital | -45.18M | -25.49M | -31.70M | -4.99M | -61.75M | |||
| Interest Paid | 3.38M | 3.38M | 3.40M | 3.07M | 2.93M | |||
| Taxes Paid | N/A | 175.00K | 180.00K | 150.00K | 250.00K | |||
| Other non cash items | 41.21M | 38.92M | 40.53M | -66.74M | 23.31M | |||
| OPERATING CASH FLOW | -15.18M | -1.95M | -65.99M | -26.72M | 1.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -24.41M | -28.75M | -30.89M | -64.14M | -29.10M | |||
| Other Investing Activity | 91.90M | 105.46M | 31.41M | -568.23M | -130.35M | |||
| INVESTING CASH FLOW | 67.49M | 76.71M | 520.00K | -632.37M | -159.44M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -40.00K | -70.00K | -760.00K | 331.36M | 91.31M | |||
| Stock Issued/Repurchased | 4.03M | 4.62M | 12.59M | 423.21M | 147.60M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -29.29M | -3.32M | |||
| FINANCING CASH FLOW | 3.99M | 4.55M | 11.83M | 725.29M | 235.60M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 56.30M | 79.31M | -53.64M | 66.20M | 77.62M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.18M | -1.95M | -65.99M | -26.72M | 1.46M | |||
| Capital Expenditure | -24.41M | -28.75M | -30.89M | -64.14M | -29.10M | |||
| FREE CASH FLOW | -39.59M | -30.70M | -96.88M | -90.86M | -27.64M | |||
All data in USD